Clearmind Medicine Inc. (CMND)
NASDAQ: CMND · Real-Time Price · USD
1.290
+0.010 (0.78%)
At close: Feb 21, 2025, 4:00 PM
1.260
-0.030 (-2.33%)
After-hours: Feb 21, 2025, 7:45 PM EST
Clearmind Medicine Income Statement
Financials in millions USD. Fiscal year is November - October.
Millions USD. Fiscal year is Nov - Oct.
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | Oct '20 Oct 31, 2020 |
| Selling, General & Admin | 4.36 | 4.76 | 3.17 | 3.03 | 0.23 | |
| Research & Development | 1.38 | 1.54 | 3.08 | 0.65 | - | |
| Operating Expenses | 5.74 | 6.3 | 6.25 | 3.69 | 0.41 | |
| Operating Income | -5.74 | -6.3 | -6.25 | -3.69 | -0.41 | |
| Interest Expense | -0.04 | -0.01 | -0.01 | - | - | |
| Interest & Investment Income | 0.27 | 0.09 | - | - | - | |
| Currency Exchange Gain (Loss) | -0.01 | -0.08 | -0 | -0.03 | - | |
| Other Non Operating Income (Expenses) | 0.71 | -2.19 | -0.29 | - | - | |
| EBT Excluding Unusual Items | -4.81 | -8.5 | -6.56 | -3.72 | -0.41 | |
| Gain (Loss) on Sale of Investments | -0.07 | -0.11 | -0.31 | - | - | |
| Pretax Income | -4.88 | -8.6 | -6.87 | -3.72 | -0.41 | |
| Income Tax Expense | 0.38 | 0.02 | 0.03 | - | - | |
| Net Income | -5.25 | -8.62 | -6.89 | -3.72 | -0.41 | |
| Net Income to Common | -5.25 | -8.62 | -6.89 | -3.72 | -0.41 | |
| Shares Outstanding (Basic) | 3 | 0 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 3 | 0 | 0 | 0 | 0 | |
| Shares Change (YoY) | 1431.07% | 367.25% | 40.19% | 70.50% | 47.00% | |
| EPS (Basic) | -1.69 | -42.58 | -159.11 | -120.34 | -22.77 | |
| EPS (Diluted) | -1.69 | -42.58 | -159.11 | -120.34 | -22.77 | |
| Free Cash Flow | -4.86 | -6.3 | -3.73 | -2.87 | -0.27 | |
| Free Cash Flow Per Share | -1.57 | -31.12 | -86.07 | -92.79 | -15.14 | |
| EBITDA | -5.73 | -6.28 | -6.23 | -3.67 | -0.23 | |
| D&A For EBITDA | 0.01 | 0.02 | 0.02 | 0.01 | 0.18 | |
| EBIT | -5.74 | -6.3 | -6.25 | -3.69 | -0.41 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.